Here is the top of page

This is the navigation link for moving toward in this page.

Go to main contents
Go to footer contents

Home

Investors
Reports & Presentations
Investor Events

Investors

Print

Text size: view with small font size; view with medium font size; view with large font size

Investors

Investor Events

Update on burosumab (KRN23): Clinical and regulatory updates, and pre-launch activities in the US and EU

October 27, 2017

Agenda （388KB）
Clinical/Regulatory Updates of Burosumab and The Current Pre-launch Activities in EU （827KB）